Clinical effectiveness and safety of pulsed-field ablation for AF same in males and females: JAMA Dr. Prem Aggarwal5 Nov 2023 5:00 PM ISTRecent studies examining the impact of patient sex on clinical outcomes following traditional thermal atrial fibrillation (AF) ablation methods, like...
High concordance in high Lp(a) levels among first- and second-degree relatives, finds study Medha Baranwal13 Oct 2023 10:30 AM ISTUSA: Findings from a cross-sectional study suggested over 40% yield of cascade screening of first-degree relatives of people with high lipoprotein(a)...
Enteric-Coated vs. Uncoated Aspirin: Balancing Effectiveness and Safety in CVD Prevention Dr.Niharika Harsha B9 Oct 2023 11:15 AM IST A recent secondary analysis of the ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness) trial...
Mirabegron therapy does not prevent progression to Heart Failure: Study Isra Zaman25 Sept 2023 9:30 AM ISTMirabegron therapy showed no significant impact on left ventricular mass or diastolic function over 12 months in patients with structural heart...
Evinacumab effective and well tolerated for LDL cholesterol lowering in refractory hypercholesterolemia patients: JAMA Medha Baranwal19 Sept 2023 11:30 AM ISTUSA: A recent study published in JAMA Cardiology has demonstrated the potential utility of evinacumab as an effective and generally well-tolerated...
Health claims of fish oil supplements often vague and lack backing by trial data: JAMA Dr. Kamal Kant Kohli16 Sept 2023 12:15 PM ISTUSA: A recent cross-sectional study has shown that the majority of fish oil supplement labels make health claims, usually in the form of...
Change in percent atheroma volume could be surrogate marker for adverse CV events: JAMA Medha Baranwal16 Sept 2023 11:45 AM ISTCanada: In a comprehensive meta-analysis published in JAMA Cardiology by Iulia Iatan and colleagues related to lipid-lowering therapy trials, a 1%...
Presence of FFR–negative high-risk non-culprit plaque tied to worse clinical outcomes in patients with MI: JAMA Medha Baranwal15 Sept 2023 8:00 PM ISTNetherlands: A recent study published in JAMA Cardiology showed an association between the presence of a fractional flow reserve (FFR)–negative...
Valsartan fails to slow cardiac remodeling among patients of subclinical HCM: JAMA Medha Baranwal14 Sept 2023 9:45 AM ISTUSA: Recent findings from the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) trial published in...
Low NT-proBNP levels associated with high Insulin resistance among healthy adults: JAMA Medha Baranwal9 Sept 2023 11:15 AM ISTUSA: A recent study published in JAMA Cardiology has suggested an inverse relationship between insulin resistance (IR) and N-terminal pro-B-type...
Mavacamten Shows Promise in Reducing Need for Invasive Treatment in Hypertrophic Cardiomyopathy Patients Dr. Kamal Kant Kohli6 Sept 2023 11:15 AM ISTPatients with severely symptomatic obstructive hypertrophic cardiomyopathy (HCM) often face a challenging dilemma: whether to opt for invasive...
Mavacamten new hope for patients with symptomatic obstructive hypertrophic cardiomyopathy Niveditha Subramani1 Sept 2023 10:00 AM ISTHypertrophic cardiomyopathy (HCM) is a myocardial disorder clinically characterized by left ventricular (LV) hypertrophy which is usually inherited....
